|
Volumn 41, Issue 2, 2006, Pages 176-191
|
3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances
|
Author keywords
Antibacterial; Indole derivatives; Mycobacterium smegmatis; Resistant Staphylococcus aureus; SAR study
|
Indexed keywords
1 METHYL 3 BROMO 4 (1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 BUTYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 ETHYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 HEPTYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 HEXYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 METHYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 PENTYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 PHENYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 (2 PROPYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 [2 (2 METHOXYPHENYL) 1H 3 INDOLYL] 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 [2 (3 METHOXYPHENYL) 1H 3 INDOLYL] 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
1 METHYL 3 BROMO 4 [2 (4 METHOXYPHENYL) 1H 3 INDOLYL] 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)PROPIONYLAMIDE;
3 BROMO 4 (1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 BROMO 4 (2 BUTYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 BROMO 4 (2 ETHYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 BROMO 4 (2 METHYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 BROMO 4 (2 PENTYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
3 BROMO 4 (2 PROPYL 1H 3 INDOLYL) 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE;
4 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)BUTANOYLAMIDE;
5 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)PENTANOYLAMIDE;
6 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)HEXANOYLAMIDE;
7 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)HEPTANOYLAMIDE;
8 [3 (4 BROMO 2,5 DIHYDRO 1H 2,5 PYRROLEDIONE 3 YL) 1H 2 INDOLYL] N (2 METHYLPHENYL)OCTANOYLAMIDE;
ANTIINFECTIVE AGENT;
CIPROFLOXACIN;
DOXYCYCLINE;
PYRROLE DERIVATIVE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VANCOMYCIN;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACTERIAL STRAIN;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG MECHANISM;
DRUG STRUCTURE;
DRUG SYNTHESIS;
GRAM POSITIVE BACTERIUM;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM SMEGMATIS;
NONHUMAN;
STAPHYLOCOCCUS AUREUS;
STRUCTURE ACTIVITY RELATION;
ANTI-BACTERIAL AGENTS;
CIPROFLOXACIN;
DOXYCYCLINE;
DRUG RESISTANCE, MICROBIAL;
GRAM-POSITIVE BACTERIA;
INDOLES;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM SMEGMATIS;
PYRROLES;
STAPHYLOCOCCUS AUREUS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VANCOMYCIN;
|
EID: 33644944497
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2005.10.006 Document Type: Article |
Times cited : (52)
|
References (33)
|